These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 32247375)

  • 1. Selective neuronal vulnerability in Parkinson's disease.
    Gonzalez-Rodriguez P; Zampese E; Surmeier DJ
    Prog Brain Res; 2020; 252():61-89. PubMed ID: 32247375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of dopaminergic neuron loss in Parkinson's disease.
    Surmeier DJ
    FEBS J; 2018 Oct; 285(19):3657-3668. PubMed ID: 30028088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease.
    Geibl FF; Henrich MT; Xie Z; Zampese E; Ueda J; Tkatch T; Wokosin DL; Nasiri E; Grotmann CA; Dawson VL; Dawson TM; Chandel NS; Oertel WH; Surmeier DJ
    Mol Neurodegener; 2024 Oct; 19(1):69. PubMed ID: 39379975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.
    Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA
    J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease.
    Tan Y; Sgobio C; Arzberger T; Machleid F; Tang Q; Findeis E; Tost J; Chakroun T; Gao P; Höllerhage M; Bötzel K; Herms J; Höglinger G; Koeglsperger T
    Acta Neuropathol; 2020 Feb; 139(2):319-345. PubMed ID: 31768670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
    Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology roadmap in Parkinson disease.
    Surmeier DJ; Sulzer D
    Prion; 2013; 7(1):85-91. PubMed ID: 23324593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery.
    Picca A; Guerra F; Calvani R; Romano R; Coelho-Júnior HJ; Bucci C; Marzetti E
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal vulnerability, pathogenesis, and Parkinson's disease.
    Sulzer D; Surmeier DJ
    Mov Disord; 2013 Jan; 28(1):41-50. PubMed ID: 22791686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease.
    Yao MF; Dang T; Wang HJ; Zhu XZ; Qiao C
    Behav Brain Res; 2024 Feb; 459():114811. PubMed ID: 38103871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation and propagation of α-synuclein aggregation in the nervous system.
    Hijaz BA; Volpicelli-Daley LA
    Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein.
    Vicario M; Cieri D; Vallese F; Catoni C; Barazzuol L; Berto P; Grinzato A; Barbieri L; Brini M; Calì T
    Cell Death Dis; 2019 Nov; 10(11):857. PubMed ID: 31719530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium signaling in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Cell Tissue Res; 2014 Aug; 357(2):439-54. PubMed ID: 24781149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons.
    Dryanovski DI; Guzman JN; Xie Z; Galteri DJ; Volpicelli-Daley LA; Lee VM; Miller RJ; Schumacker PT; Surmeier DJ
    J Neurosci; 2013 Jun; 33(24):10154-64. PubMed ID: 23761910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.